Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.47USD
6:56pm GMT
Change (% chg)

$0.00 (+0.14%)
Prev Close
$3.47
Open
$3.50
Day's High
$3.50
Day's Low
$3.47
Volume
1,001
Avg. Vol
11,838
52-wk High
$5.34
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 1.50 1.50 1.50 --
Quarter Ending Jun-19 1 1.50 1.50 1.50 --
Year Ending Dec-19 2 3.00 6.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 1 -0.04 -0.04 -0.04 -0.28
Quarter Ending Jun-19 1 -0.03 -0.03 -0.03 -0.30
Year Ending Dec-19 2 -0.39 -0.12 -0.66 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta 1.54 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 10.34 10.16 5.27
Price to Tangible Book (MRQ) 10.39 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 12.71 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.04 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 16.50 9.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 10.80 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.68 8.31
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,725 844,239,694
Net Income/Employee (TTM) -- 652,578 100,064,161
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 6.45 11.08
Return on Assets - 5 Yr. Avg. -71.19 5.52 12.21
Return on Investment (TTM) -52.76 8.99 14.48
Return on Investment - 5 Yr. Avg. -91.15 6.85 15.88
Return on Equity (TTM) -52.76 10.13 15.99
Return on Equity - 5 Yr. Avg. -93.46 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.41 -8.67 22 99
13 Week -10.67 -15.02 31 95
26 Week 0.25 -7.37 53 98
52 Week 66.12 40.80 82 72
YTD 58.27 38.99 77 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.80%
# of Holders: 41
Total Shares Held: 2,444,301
3 Mo. Net Change: -4,247
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.